Maja Tomicic

Group leader/Associate Professor

University Medical Center of the Johannes Gutenberg University Mainz

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Maja Tomicic is an Associate Professor and Group Leader at the University Medical Center of the Johannes Gutenberg University Mainz, Germany. Her research focuses on cellular senescence, particularly in the context of glioblastoma and colorectal cancer, exploring mechanisms related to the p21CIP1-CDK axis, genotoxic stress, and resistance to therapy. She has published extensively on the molecular profiles affecting cancer resistance and the roles of epigenetic alterations in tumor biology.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Petra Heffeter

Full professor

Medical University of Vienna

AUSTRIA

View details

Bernd Kaina

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maja Tomicic

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Therapy-induced senescence of glioblastoma cells is determined by the p21CIP1-CDK1/2 axis and does not require activation of DREAM

The p21CIP1-CDK4-DREAM axis is a master regulator of genotoxic stress-induced cellular senescence

Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer

Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?

Epigenetic Alterations Upstream and Downstream of p53 Signaling in Colorectal Carcinoma

Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment

Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14<sup>ARF</sup>-Mediated Sustained p53 Activation

Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination

Benzo[a]pyrene represses DNA repair through altered E2F1/E2F4 function marking an early event in DNA damage-induced cellular senescence

Collaborators (2)

Petra Heffeter

Bernd Kaina

Make your next move.